2026 Lipid-Management Guidelines for High-Risk Patients:Cutting-Edge Strategies to Halt Atherosclerosis Progression
by Prateek Chopra | June 16, 2026 | Cardiology Conferences | ESH 2026 Therapeutic Challenge: Despite advances in lipid-lowering therapy (LLT), guideline-recommended LDL-C targets remain poorly achieved among patients with established atherosclerotic cardiovascular disease (ASCVD). Residual cardiovascular risk persists, highlighting the need for earlier and more intensive lipid-lowering strategies. Study Evidence: Guideline Recommendations: Emerging Clinical Evidence: The 2026 lipid-management paradigm emphasizes […]